This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
About us
We share an ambition to transform healthcare and improve human lives through AI-guided precision solutions.
About Quibim
At Quibim, we design pioneering tools that unlock imaging data to improve patient outcomes.
After years of intense research in imaging biomarkers, Quibim (QUantitative Imaging Biomarkers In Medicine) did the commercial launch and internationalization in 2021. Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers. The business model is based on a platform marketed through SaaS for hospitals and value-based partnerships in life sciences that help to identify new market needs and create new algorithms.
Having expanded internationally and with a growing team, we are now heading up to bring a new line of products based on predictive imaging biomarker panels.